title: Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
abstract: We tested the hypothesis that genes involved in the alcohol oxidation pathway modify the association between alcohol intake and breast cancer. Subjects were women aged 55-74 at baseline from the screening arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Incident breast cancers were identified through annual health surveys. Controls were frequency matched to cases by age and year of entry into the trial. A self-administered food frequency questionnaire queried frequency and usual serving size of beer, wine or wine coolers, and liquor. Three SNPs in genes in the alcohol metabolism pathway were genotyped: alcohol dehydrogenase 2, alcohol dehydrogenase 3, and CYP2E1. The study included 1,041 incident breast cancer cases and 1,070 controls. In comparison to non-drinkers, the intake of any alcohol significantly increased the risk of breast cancer, and this risk increased with each category of daily alcohol intake (OR 2.01, 95% CI 1.14, 3.53) for women who drank three or more standard drinks per day. Stratification by genotype revealed significant gene/environment interactions. For the ADH1B gene, there were statistically significant associations between all levels of alcohol intake and risk of breast cancer (all OR > 1.34 and all lower CI > 1.01), while for women with the GA or AA genotype, there were no significant associations between alcohol intake and risk of breast cancer. Alcohol intake, genes involved in alcohol metabolism and their interaction increase the risk of breast cancer in post-menopausal women. This information could be useful for primary care providers to personalize information about breast cancer risk reduction.
authors.affiliation: Essentia Institute of Rural Health, Duluth, MN 55805, USA. cmccarty@eirh.org
authors.forename: Catherine A
authors.initials: CA
authors.lastname: McCarty
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: Reding
authors.forename: John
authors.initials: J
authors.lastname: Commins
authors.forename: Craig
authors.initials: C
authors.lastname: Williams
authors.forename: Meredith
authors.initials: M
authors.lastname: Yeager
authors.forename: James K
authors.initials: JK
authors.lastname: Burmester
authors.forename: Catherine
authors.initials: C
authors.lastname: Schairer
authors.forename: Regina G
authors.initials: RG
authors.lastname: Ziegler
mesh_terms: D000368:Aged; D000426:Alcohol Dehydrogenase / Q000235:genetics; D000428:Alcohol Drinking / Q000235:genetics*; D000080924:Aldehyde Dehydrogenase 1 Family; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics*; D016022:Case-Control Studies; D055088:Early Detection of Cancer; D000431:Ethanol / Q000378:metabolism; D005260:Female; D005838:Genotype; D006801:Humans; D015994:Incidence; D007527:Isoenzymes / Q000235:genetics; D008403:Mass Screening; D008875:Middle Aged; D050697:Retinal Dehydrogenase / Q000235:genetics; D012306:Risk
chemical_list: D007527:Isoenzymes; D000431:Ethanol; D000426:Alcohol Dehydrogenase; D000080924:Aldehyde Dehydrogenase 1 Family; C510223:ALDH1A1 protein, human; D050697:Retinal Dehydrogenase